Highmark Health announced today that through its VITAL Innovation Program, a test-and-learn platform, it will be evaluating WellDoc’s® BlueStar® mobile app, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes.
{iframe}https://www.prnewswire.com/news-releases/highmark-healths-vital-innovation-program-to-evaluate-welldocs-bluestar-mobile-app-for-improving-outcomes-among-type-2-diabetes-patients-300640075.html{/iframe}